Greener Pharmaceuticals' Regulatory Highway

As climate change continues to exacerbate health risks worldwide, modern health systems, contributing to approximately 5% of global carbon emissions, must prioritize sustainability.

WHO, through its Department of Regulation and Prequalification, has issued a call for action urging global regulatory bodies and stakeholders in the pharmaceutical and healthcare industries to adopt innovative practices that prioritize sustainability and reduce environmental impact.